Your browser doesn't support javascript.
loading
Heinz body hemolysis following extended use phenazopyridine in a post-HCT patient with hemorrhagic cystitis: An old problem for a new generation.
Ferdjallah, Asmaa; Long, Susie; Dayton, Vanessa; Gupta, Ashish O.
Affiliation
  • Ferdjallah A; Division of Blood and Marrow Transplant and Cellular Therapy, Department of Pediatrics University of Minnesota Minneapolis Minnesota USA.
  • Long S; MHealth Fairview, Acute Care Pharmacy Services Minneapolis Minnesota USA.
  • Dayton V; Department of Pathology, Hematopathology University of Minnesota Minneapolis Minnesota USA.
  • Gupta AO; Division of Blood and Marrow Transplant and Cellular Therapy, Department of Pediatrics University of Minnesota Minneapolis Minnesota USA.
Clin Case Rep ; 11(3): e7012, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36911643
Hemorrhagic cystitis is a common complication following the use of cyclophosphamide. Associated dysuria can be painful and there are few good options to relieve pain. Phenazopyridine has historically been utilized for dysuria and is available over the counter. However, it is associated with hematologic side effects with prolonged use. Here we present a case of a patient who developed Heinz body hemolysis following prolonged administration of phenazopyridine to treat cyclophosphamide-induced hemorrhagic cystitis following hematopoietic stem cell transplant.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2023 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2023 Document type: Article Country of publication: United kingdom